These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 11338051)
1. Physical and biological dosimetry in patients undergoing radiosynoviorthesis with erbium-169 and rhenium-186. Manil L; Voisin P; Aubert B; Guerreau D; Verrier P; Lebègue L; Wargnies JP; Di Paola M; Barbier Y; Chossat F; Menkes CJ; Tébib J; Devaux JY; Kahan A Nucl Med Commun; 2001 Apr; 22(4):405-16. PubMed ID: 11338051 [TBL] [Abstract][Full Text] [Related]
2. Biological dosimetry after radiosynoviorthesis with rhenium-186 sulphide and erbium-169 citrate. Klett R; Schnurbus-Duhs A; Mödder G; Schmid E; Voth M Nuklearmedizin; 2012; 51(1):17-25. PubMed ID: 21931934 [TBL] [Abstract][Full Text] [Related]
3. Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis. Gratz S; Göbel D; Behr TM; Herrmann A; Becker W J Rheumatol; 1999 Jun; 26(6):1242-9. PubMed ID: 10381037 [TBL] [Abstract][Full Text] [Related]
4. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment. Torres M; Ayra E; Albuerne O; Montano Delgado MA Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831 [TBL] [Abstract][Full Text] [Related]
5. Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis (RA): a two-year follow-up randomized controlled multicentre study. Tebib JG; Manil LM; Mödder G; Verrier P; De Rycke Y; Bonmartin A; Devaux JY; Chossat F; Menkes CJ; Kahan A Clin Exp Rheumatol; 2004; 22(5):609-16. PubMed ID: 15485015 [TBL] [Abstract][Full Text] [Related]
6. Radiation exposure of hemophiliacs after radiosynoviorthesis with 186Re colloid. Grmek M; Milcinski M; Fettich J; Brecelj J Cancer Biother Radiopharm; 2007 Jun; 22(3):417-22. PubMed ID: 17651049 [TBL] [Abstract][Full Text] [Related]
7. Radiosynoviorthesis of acromioclavicular joint using 169Er-citrate: prospective evaluation of efficacy. Vereb M; Liepe K; Fischer M; Kaliska L; Noskovicova L; Balogova S Nucl Med Rev Cent East Eur; 2018; 21(1):26-31. PubMed ID: 29319135 [TBL] [Abstract][Full Text] [Related]
8. [Chronic polyarthritis and radiosynoviorthesis: a prospective, controlled study of injection therapy with erbium 169 and rhenium 186]. Göbel D; Gratz S; von Rothkirch T; Becker W Z Rheumatol; 1997; 56(4):207-13. PubMed ID: 9417761 [TBL] [Abstract][Full Text] [Related]
9. Radiation synovectomy with (90)Yttrium, (186)Rhenium and (169)Erbium: a systematic literature review with meta-analyses. van der Zant FM; Boer RO; Moolenburgh JD; Jahangier ZN; Bijlsma JW; Jacobs JW Clin Exp Rheumatol; 2009; 27(1):130-9. PubMed ID: 19327243 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of radiosynovectomy in rheumatoid arthritis. Liepe K Rheumatol Int; 2012 Oct; 32(10):3219-24. PubMed ID: 21964982 [TBL] [Abstract][Full Text] [Related]
11. 169Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints. Kahan A; Mödder G; Menkes CJ; Verrier P; Devaux JY; Bonmartin A; De Rycke Y; Manil L; Chossat F; Tebib J Clin Exp Rheumatol; 2004; 22(6):722-6. PubMed ID: 15638046 [TBL] [Abstract][Full Text] [Related]
12. [188Re]Rhenium sulfide suspension: a potential radiopharmaceutical for tumor treatment following intra-tumor injection. Junfeng Y; Duanzhi Y; Xiaofeng M; Zili G; Jiong Z; Yongxian W; Knapp FF Nucl Med Biol; 1999 Jul; 26(5):573-9. PubMed ID: 10473197 [TBL] [Abstract][Full Text] [Related]
14. [Principles of radiosynoviorthesis]. Müller-Brand J Schweiz Med Wochenschr; 1990 May; 120(18):676-9. PubMed ID: 2343281 [TBL] [Abstract][Full Text] [Related]
15. Double-blind study of erbium 169 injection (synoviorthesis) in rheumatoid digital joints. Menkes CJ; Gô AL; Verrier P; Aignan M; Delbarre F Ann Rheum Dis; 1977 Jun; 36(3):254-6. PubMed ID: 327948 [TBL] [Abstract][Full Text] [Related]
16. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results. Caveliers V; Goodbody AE; Tran LL; Peers SH; Thornback JR; Bossuyt A J Nucl Med; 2001 Jan; 42(1):154-61. PubMed ID: 11197967 [TBL] [Abstract][Full Text] [Related]
18. A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. Buffa FM; Flux GD; Guy MJ; O'Sullivan JM; McCready VR; Chittenden SJ; Dearnaley DP Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1114-24. PubMed ID: 12761596 [TBL] [Abstract][Full Text] [Related]
19. The effect of the beta-emitting yttrium-90 citrate on the dose-response of dicentric chromosomes in human lymphocytes: a basis for biological dosimetry after radiosynoviorthesis. Schmid E; Selbach HJ; Voth M; Pinkert J; Gildehaus FJ; Klett R; Haney M Radiat Environ Biophys; 2006 Jul; 45(2):93-8. PubMed ID: 16733726 [TBL] [Abstract][Full Text] [Related]
20. Radiation synovectomy of the upper extremity joints: does leakage from the joint to non-target organs impair its therapeutic effect? van der Zant FM; Jahangier ZN; Gommans GG; Moolenburgh JD; Jacobs JW Appl Radiat Isot; 2007 Jun; 65(6):649-55. PubMed ID: 17350269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]